11/30/2023	Midland Vet Services
Issuing Office Center for Veterinary Medicine Subject Unapproved Medically Important Antimicrobials Marketed for Use in Non-food Minor Species Response Letter Closeout Letter

 

Issuing Office Center for Veterinary Medicine

Subject Unapproved Medically Important Antimicrobials Marketed for Use in Non-food Minor Species

Response Letter

Closeout Letter

 

Company Name Silver Lease, LLC

Issuing Office Center for Veterinary Medicine

Subject Unapproved Medically Important Antimicrobials Marketed for Use in Non-food Minor Species

Response Letter

Closeout Letter

 

Company Name Midland Vet Services

Issuing Office Center for Veterinary Medicine

Subject Unapproved Medically Important Antimicrobials Marketed for Use in Non-food Minor Species

Response Letter

Closeout 

 

Company Name Aquarium Pharmacy LLC

Issuing Office Center for Veterinary Medicine

Subject Unapproved Medically Important Antimicrobials Marketed for Use in Non-food Minor Species

Response Letter

Closeout Letter

 

12/14/2023	11/30/2023
Company Name California Veterinary Supply Issuing Office Center for Veterinary Medicine Subject Unapproved Medically Important Antimicrobials Marketed for Use in Non-food Minor Species Response Letter Closeout Letter

 

Company Name American Aquarium Products

Issuing Office Center for Veterinary Medicine

Subject Unapproved Medically Important Antimicrobials Marketed for Use in Non-food Minor Species

Response Letter

Closeout Letter

 

Company Name Aquanest Biotic

Issuing Office Center for Veterinary Medicine

Subject Unapproved Medically Important Antimicrobials Marketed for Use in Non-food Minor Species

Response Letter

Closeout Letter

 PBM bills drove lobbying spending in 2023

Legislation targeting pharmacy benefit managers has attracted the highest levels of lobbying this ye...

Read more

 

• Draft Guidance: Interim Policy on Compounding Using Bulk Drug Substances Under Section 503A of the Federal Food, Drug, and Cosmetic Act
• Draft Guidance: Interim Policy on Compounding Using Bulk Drug Substances Under Section 503B of the Federal Food, Drug, and Cosmetic Act - Revision 2